Stefano Benvegnù

Stefano Benvegnù

Auto-generated profile, based on publicly available information

Stefano Benvegnù

Alzheimer's Research UK UCL Drug Discovery Institute, University College London, Cruciform Building, Gower Street, London, WC1E 6BT, UK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
EPErnest Palomer
Ernest Palomer
JCJavier Carretero
Javier Carretero
SBStefano Benvegnù
Stefano Benvegnù
CDCarlos G. Dotti
Carlos G. Dotti
MMMauricio G. Martin
Mauricio G. Martin
It has been recently described that in embryonic stem cells, the expression of some important developmentally regulated genes is repressed, but poised for fast activation under the appropriate stimuli. In this work we show that Bdnf promoters are repressed by Polycomb Complex 2 in mature hippocampal neurons, and basal expression is guaranteed by the coexistence with activating histone marks. Neuronal stimulation triggered by N-methyl-D-aspartate application induces the transcription of these promoters by H3K27Me3 demethylation and H3K27Me3 phosphorylation at Serine 28 leading to displacement of EZH2, the catalytic subunit of Polycomb Repressor Complex 2. Our data show that the fast transient expression of Bdnf promoters II and VI after neuronal stimulation is dependent on acetylation of histone H3K27 by CREB-p/CBP. Thus, regulatory mechanisms established during development seem to remain after differentiation controlling genes induced by different stimuli, as would be the case of early memory genes in mature neurons.

13 September 2016 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
APA Pérez-Cañamás
A Pérez-Cañamás
SBS Benvegnù
S Benvegnù
CRC B Rueda
C B Rueda
ARA Rábano
A Rábano
JSJorgina Satrustegui
Jorgina Satrustegui
MLM D Ledesma
M D Ledesma

16 February 2010 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
SBStefano Benvegnù
Stefano Benvegnù
IPIlaria Poggiolini
Ilaria Poggiolini
Giuseppe LegnameGiuseppe Legname
Giuseppe Legname

1 June 2011 in Physiological Genomics
Verified
Journal Article
Closed access
PDF file
SBStefano Benvegnù
Stefano Benvegnù
PRPaola Roncaglia
Paola Roncaglia
FAFederica Agostini
Federica Agostini
CCCristina Casalone
Cristina Casalone
CCCristiano Corona
Cristiano Corona
Giuseppe LegnameGiuseppe Legname
Giuseppe Legname
The conversion of the cellular prion protein (PrPC) to an abnormal and protease-resistant isoform is the key event in prion diseases. Mice lacking PrPCare resistant to prion infection, and downregulation of PrPCduring prion infection prevents neuronal loss and the progression to clinical disease. These results are suggestive of the potential beneficial effect of silencing PrPCduring prion diseases. However, the silencing of a protein that is widely expressed throughout the central nervous system could be detrimental to brain homeostasis. The physiological role of PrPCremains still unclear, but several putative functions (e.g., neuronal development and maintenance) have been proposed. To assess the influence of PrPCon gene expression profile in the mouse brain, we undertook a microarray analysis by using RNA isolated from the hippocampus at two different developmental stages: newborn (4.5-day-old) and adult (3-mo-old) mice, both from wild-type and Prnp0/0animals. Comparing the different datasets allowed us to identify “commonly” co-regulated genes and “uniquely” deregulated genes during postnatal development. The absence of PrPCaffected several biological pathways, the most representative being cell signaling, cell-cell communication and transduction processes, calcium homeostasis, nervous system development, synaptic transmission, and cell adhesion. However, there was only a moderate alteration of the gene expression profile in our animal models. PrPCdeficiency did not lead to a dramatic alteration of gene expression profile and produced moderately altered gene expression levels from young to adult animals. Thus, our results may provide additional support to silencing endogenous PrPClevels as therapeutic approach to prion diseases.

22 April 2021 in Future Medicinal Chemistry
Verified
Journal Article
Open access
Yuguang ZhaoYuguang Zhao
Yuguang Zhao
SJSarah Jolly
Sarah Jolly
SBStefano Benvegnu
Stefano Benvegnu
EJE Yvonne Jones
E Yvonne Jones
PFPaul V Fish
Paul V Fish
Notum has recently been identified as a negative regulator of Wnt signaling through the removal of an essential palmitoleate group from Wnt proteins. There are emerging reports that Notum plays a r...

1 May 2017 in Molecular Cell
Verified
Journal Article
Closed access
SBStefano Benvegnù
Stefano Benvegnù
MMMaría Inés Mateo
María Inés Mateo
EPErnest Palomer
Ernest Palomer
JJJerónimo Jurado-Arjona
Jerónimo Jurado-Arjona
CDCarlos G. Dotti
Carlos G. Dotti